+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Advanced Therapy Medicinal Product"

RP-L102 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RP-L102 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Cell and Gene Therapy CROs Market, 2018-2030 - Product Thumbnail Image

Cell and Gene Therapy CROs Market, 2018-2030

  • Report
  • October 2018
  • 238 Pages
  • Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Advanced Therapy Medicinal Products (ATMPs) are a class of pharmaceuticals that are used to treat serious or life-threatening diseases and conditions. They are based on gene therapy, somatic cell therapy, and tissue engineering, and are designed to modify or replace a patient's cells or tissues. ATMPs are highly complex and require specialized manufacturing processes, and are subject to stringent regulatory requirements. ATMPs are used to treat a wide range of diseases, including cancer, genetic disorders, and degenerative diseases. They are also used to treat conditions such as organ failure, autoimmune diseases, and cardiovascular diseases. ATMPs are often used in combination with other treatments, such as chemotherapy or radiation therapy. Some companies in the ATMP market include Novartis, Gilead Sciences, Celgene, and Regeneron Pharmaceuticals. Show Less Read more